Abstract
In choosing a method by which to identify drug metabolites, the quantity of material which is available is a prime consideration. In this regard, pharmacologists find themselves midway between natural products chemists and biochemists. Usually the former has reasonably large quantities of material available in a relatively high state of purity. The biochemist on the other hand, is usually forced to deal with submicrogram quantities; radioactivity may be the only objective evidence of the existence of a compound. This is a consequence of the biochemist’s use of purified enzyme preparations which only allow for the conversion of mg quantities under the carefully controlled conditions he usually wishes to maintain. Attempts to scale up such processes may bring about a whole new set of problems. The pharmacologist interested in drug metabolism deals with enzyme systems as present in intact organs or at least parts of organs (liver slices, etc.), and in general this permits conversion of somewhat larger quantities. In fact, most drugs in use today are employed at mg rather than μg levels and so the investigation of their metabolism is at least practicable. This chapter discusses the advantages and disadvantages of mass spectrometry, especially as combined with gas chromatography, for such investigations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adlercreutz, H., Johansson, C.J., Luukkainen, T.: Gas chromatographic and mass spectrometric studies in the influence of metabolites of bis (p-acetoxyphenyl) cyclohexylidenemethane on the estimation of estrogens in urine. Ann. Med. exp. Fenn. 45, 269–276 (1967).
Änggärd, E., Sedvall, G.: Gas chromatography of catecholamine metabolites using electron capture detection and mass spectrometry. Anal. Chem. 41, 1250–1256 (1969).
Alber, L.L.: All-purpose gas-liquid chromatographic column for pharmaceuticals. J. Ass. Off. Anal. Chem. 52, 1295–1300 (1969).
Anders, M.W., Mannering, G.J.: Applications of gas chromatography to toxicology. Progr. chem. Tox. 3, 121–218 (1967).
Application of Metabolic Data to the Evaluation of Drugs: A report prepared by the Committee on Problems of Drug Safety of the Drug Research Board, National Academy of Sciences — National Research Council: Clin. Pharmacol. Ther. 10, 607–634 (1969).
Arnold, W., Grutzmacher, W.F.: Massenspektrometrischer Nachweis von Arzneimittelmetaboliten (Barbiturate, Noludar, Pyramidon) in Rahmen der forensischen Analyse. Fresenius’ Z. anal. Chem. 247, 179–188 (1969).
Audier, H., Fetizon, M., Ginsburg, D., Mandelbaum, A., Rull, T.: Mass spectrometry of morphine alkaloids. Tetrahedron Letters 1, 13–22 (1965).
Bagley, G.E., Reichel, W.L., Cromartie, E.: Identification of polychlorinated biphenyls in two bald eagles by combined gas-liquid chromatography-mass spectrometry. J. Ass. Off. Anal. Chem. 53, 251–261 (1970).
Ballantine, J.A., Fenwick, R.G.: The mass spectra of griseofulvin analogues. Characteristic fragmentation processes in the mass spectra of spirocyclohexenones and spirocyclohexanones containing the griseofulvin skeleton. Org. Mass. Spect. 2, 1145–1169 (1969).
Beckett, A.H., Tucker, G.T., Moffat, A.C.: Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport. J. Pharm. Pharmacol. 19, 273–294 (1967).
Belasco, I.J., Reiser, R.W.: Metabolic fate of siduron in the animal. J. Agr. Food Chem. 17, 1000–1003 (1969).
Bellman, S.W.: Mass spectral identification of some hallucinogenic drugs. J. Ass. Off. Anal. Chem. 15, 164–175 (1968).
Beynon, J.H.: Mass spectrometry and its applications to organic chemistry. Amsterdam: Elsevier 1960.
Beynon, J.H., Hopkinson, J.A., Williams, A.E.: The mass spectra of some guanidines. Org. Mass. Spect. 1, 169–187 (1968).
Beynon, J.H., Saunders, R.A., Williams, A.E.: The mass spectra of organic molecules. Amsterdam: Elsevier 1968.
Beynon, J.H., Williams, A.E.: Mass and abundance tables for use in mass spectrometry. Amsterdam: Elsevier 1963.
Biemann, K.: Mass spectrometry, applications to organic chemistry. New York: McGraw-Hill 1962.
Biemann, K., McCloskey, J.A.: Application of mass spectrometry to structural problems. VI. Nucleosides. J. Amer. chem. Soc. 84, 2005–2007 (1962).
Biemann, K., Watson, J.T.: Recording and interpretation of high resolution mass spectra of natural products as eluted from a gas chromatograph. Monatsh. Chem. 96, 305–315 (1965).
Biros, F.J., Walker, A.C.: Pesticide residue analysis in human tissue by combined gas chromatography-mass spectrometry. J. Agr. Food Chem. 18, 425–429 (1970).
Bogentoft, C., Danielsson, B.: Studies on the medicinal chemistry of oxoquinazolines. VI. Mass spectra of isomeric N-and O-alkylated 4-oxoquinazolines. Acta pharm. Suecia 6, 589–598 (1969).
Broadhurst, N.A., Montgomery, M.L., Freed, V.H.: Metabolism of 2-methoxy-3,6-dichlorobenzoic acid (dicamba) by wheat and bluegrass plants. J. Agr. Food Chem. 14, 585–588 (1966).
Brochmann-Hanssen, E., Oke, T.O.: Gas chromatography of barbiturates, phenolic alkaloids, and xanthine bases: Flash-heater methylation by means of trimethylanflinium hydroxide. J. pharm. Sci. 58, 370–371 (1969).
Brunnee, C., Ten Noever de Brauw, M.C.: Z. Anal. Chem. 229, No. 5, 321 (1967).
Budzikiewicz, H., Djerassi, C.: Mass spectrometry in structural and stereochemical problems. I. Steroid Ketones. J. Amer. chem. Soc. 84, 1430–1439 (1962).
Budzikiewicz, H., Djerassi, C., Williams, D.H.: Interpretation of mass spectra of organic compounds. San Francisco: Holden-Day 1964.
Budzikiewicz, H., Djerassi, C., Williams, D.H.: Structure elucidation of natural products by mass spectrometry. Vol. I: Alkaloids; Vol. II: Steroids, terpinoids, sugars, and miscellaneous compounds. San Francisco: Holden-Day 1964.
Budzikiewicz, H., Djerassi, C., Williams, D.H.: Mass spectrometry of organic compounds. San Francisco: Holden-Day 1967.
Burtis, C.A., Butts, W.C., Rainey, W.T.: Separation of the metabolites of phenacetin in urine by high-resolution anion exchange chromatography. Amer. J. clin. Path. 53, 769–777 (1970).
Burtis, C.A., Warren, K.S.: Identification of urinary constituents isolated by anion-exchange chromatography. Clin. Chem. 14, 290–301 (1968).
Butenandt, A. von, Eckman, R.B., Stamm, D., Hucker, E.: Über den Sexual-Lockstoff des Seidenspinners Bombyx mori. Reindarstellung und Konstitution. Z. Naturforsch. 14b, 283–284 (1959).
Chalmers, R.A., Parker, R., Simmons, H.A., Snedden, W., Watts, R.W.E.: The conversion of 4-Hydroxypyrazolo [3,4-d] pyrimidine (Allopurinol) into 4,6-dihydroxypyrazolo [3,4-d] pyrimidine (oxipurinol) in vivo in the absence of xanthine-oxygen oxidoreductase. Biochem. J. 112, 527–532 (1969).
Cheek, F.E., Newell, S., Joffe, M.: Deceptions in the illicit drug market. Science 167, 1276 (1970).
Coutts, R.T., Hindmarsh, K.W.: Mass spectra of some quinoline hydroxamine acids and related compounds. Org. Mass. Spect. 2, 681–696 (1969).
Coutts, R.T., Locock, R.A.: Identification of medicinal barbiturates by means of mass spectrometry. J. pharm. Sci. 57, 2096–2100 (1968).
Coutts, R.T., Locock, R.A.: The (M-43)+ ion in the mass spectra of some medicinal barbiturates. J. pharm. Sci. 58, 775–776 (1969).
Coutts, R.T., Mukherjee, G.: Identification of the aromatic hydroxyamine group by mass spectrometry. Org. Mass. Spect. 3, 63–65 (1970).
Creveling, C.R., Daly, J.W.: Identification of 3,4-dimethoxyphenethylamine from schizophrenic urine by mass spectroscopy. Nature (Lond.) 216, 190–191 (1967).
Dalgliesh, C.E., Horning, E.C., Horning, M.G., Knox, K.L., Arger, K.Y.: A gas-liquid-chromatographic procedure for separating a wide range of metabolites occuring in urine or tissue extracts. Biochem. J. 101, 792–810 (1966).
Damico, J.N., Barron, R.P.: The mass spectra of some chlorinated pesticidal compounds. Org. Mass. Spect. 1, 331–342 (1968).
Damico, J.N., Chen, J.Y., Costello, C.E., Haenni, E.D.: Structure of Klein’s metabolites of aldrin and of dieldrin. J. Ass. Off. Anal. Chem. 51, 48–55 (1968).
Dejongh, D.C.: Mass spectrometry, Annual Review in Analytical Chemistry. Anal. Chem. 42, No. 5 169R–205R (1970).
Dejongh, D.C., Perricone, S.C., Gay, M.L., Korytnyk, W.: Mass spectrometry of vitamin B6: Different forms of the vitamin, its metabolites, and antimetabolites, and analogs. Org. Mass. Spect. 1, 151–166 (1968).
Dreyfuss, J., Cohen, A.L., Hess, S.M.: Metabolism of thiazesim, 5-(2-dimethylaminoethyl)-2,3-dehydro-2-phenyl-1,5-benzothiazepin-4 (SH)-one in the rat in vivo and in vitro. J. pharm. Sci. 57, 1505–1511 (1968).
Duckworth, H.E.: Mass spectrometry. London: Cambridge Univ. Press 1953.
Duffield, A.M., Craig, J.C., Kray, L.R.: Electron impact promoted fragmentation of some phenothiazine derivatives. Tetrahedron 24, 4267–4276 (1968).
Emery, E.M.: Mass spectra of aromatic esters. Anal. Chem. 32, 1495–1506 (1960).
Eneroth, P., Hellstrom, K., Ryhage, R.: Identification of two neutral metabolites of stigma sterol found in human feces. Steroids 6, 707–719 (1965).
Ettre, L.S., Zlatkis, A.: The practice of gas chromatography. New York: Interscience 1967.
Fales, H.M., Haahti, E.O.A., Luukkainen, T., Vanden Heuvel, W.J.A., Horning, E.C.: Milligram-scale preparative gas chromatography of steroids and alkaloids. Anal. Biochem. 4, 296–305 (1962).
Fales, H.M., Lloyd, H.A., Milne, G.W.A.: Chemical ionization mass spectrometry of complex molecules. II. Alkaloids. J. Amer. chem. Soc. 92, 1590–1597 (1970).
Fales, H.M., Milne, G.W.A., Vestal, M.C.: Chemical ionization mass spectrometry. J. Amer. chem. Soc. 91, 3682–3685 (1969).
Field, F.H.: Chemical ionization mass spectrometry. Accounts Chem. Res. 1, 42–49 (1968).
Field, F.H., Franklin, J.L.: Electron impact phenomena. New York: Academic Press 1957.
Friedland, S.S., Lane, G.H., Longman, R.T., Train, K.E., O’Neal, M.J.: Mass spectra of steroids. Anal. Chem. 31, 169–174 (1959).
Friedman, A.R., Lemin, A.J.: Metabolism of 2-chloro-4,5-dimethyl phenyl N-methylcarbamate in bean plants. J. Agr. Food Chem. 15, 642–647 (1967).
Fukami, J.I., Yamamoto, I., Casida, J.E.: Metabolism of rotenone in vitro by tissue homogenates from mammals and insects. Science 155, 713–716 (1967).
Gardiner, J.A., Reiser, R.W., Sherman, H.: Identification of the metabolites of bromacil in rat urine. J. Agr. Food Chem. 17, 967–973 (1969).
Gilbert, J.N.T., Millard, B.J.: Pharmacologically interesting compounds — I: High resolution mass spectra of phenothiazines. Org. Mass. Spect. 2, 17–31 (1969).
Goldman, P., Milne, G.W.A., Keister, D.B.: Carbon-halogen bond clevage III. Studies on bacterial halidohydrolases. J. biol. Chem. 243, 428–434 (1968).
Granstrom, E., Samuelsson, B.: The structure of the main urinary metabolite of prostaglandin F2 α in the guinea pig. Europ. J. Biochem. 10, 411–418 (1969).
Gray, G.M.: Gas chromatography. In: Tools of biological research. Ed by H.J.B. Atkins. Vol. 3, pp. 79–97 Springfield, Ill.: Thomas 1961.
Grützmacher, H.F., Arnold, W.: Massenspektren von Barbitursäurederivaten. Tetrahedron Letters 13, 1365–1374 (1966).
Guarino, A.M., Conway, W.D., Fales, H.M.: Mass spectral identification of probenecid metabolites in rat bile. Europ. J. Pharmacol. 8, 244–252 (1969).
Gudzinowicz, B.J.: Gas chromatographic analysis of drugs and pesticides. New York: Marcel Dekker, Inc. 1967.
Hammar, C.G., Hanin, I., Holmstedt, B., Kitz, R.J., Jenden, D.J., Karlen, B.: Identification of acetylcholine in fresh rat brain by combined gas chromatography-mass spectrometry. Nature (Lond.) 220, 915–917 (1968).
Hammar, C.G., Holmstedt, B., Ryhage, R.: Mass Fragmentography. Identification of chlorpromazine and its metabolites in human blood by a new method. Anal. Biochem. 25, 532–548 (1968).
Hoffman, D.R.: The mass spectra of tetracyclines. J. Org. Chem. 31, 792–796 (1966).
Holtzman, J., Gillette, J.R., Milne, G.W.A.: The metabolic products of naphthalene in mammalian systems. J. Amer. chem. Soc. 89, 6341–6344 (1967).
Holzapfel, C.W.: The isolation and structure of cyclopiazonic acid, a toxic metabolite of Penicillium Cyclopium Westling. Tetrahedron 24, 2101–2119 (1968).
Horning, M.G., Waterbury, L.D., Horning, E.C., Hill, R.M.: Placenta; transfer of drugs: Drugs and drug metabolites in the neonate. In: The foetoplacental unit. Ed. by A. Pecile and C. Finzi, pp. 305–312. Excerpta med. (Amst.) 1969.
Jaakomaki, P.I., Knox, K.L., Horning, E.C., Horning, M.G.: The characterization by gas-liquid chromatography of ethyl β-D-glucosiduronic acid as a metabolite of ethanol in rat and man. Europ. J. Pharmacol. 1, 63–70 (1967).
Jansson, B.O., Larsson, B.T.: Analysis of organic compounds in human breath by gas chromatography-mass spectrometry. J. Lab. clin. Med. 74, 961–966 (1969).
Johnson, R.A., Herr, M.E., Murray, H.C., Reineke, L.M., Fonken, G.S.: The microbiological oxygenation of some azabicycloalkanes. J. Org. Chem. 33, 3195 (1968).
Jorg, J., Houriet, R., Spiteller, G.: Massenspektren von Pflanzenschutzmitteln. Monatsh. Chem. 97, 1064–1087 (1966).
Kabasakalian, P., Taggart, M., Townley, E.: Urinary excretion of chloropheniramine and its N-demethylated metabolites in man. J. pharm. Sci. 57, 856–858 (1968).
Karlen, B., Bogentoft, C.: A mass spectrometric investigation of tremorine and related acetylenic amines and amides. Acta. pharm. Suecica 6, 543–560 (1969).
Kuehl, F.A., Ormond, R.E., Vandenheuvel, W.J.A.: Occurrence of 3,4-dimethoxyphenyl acetic acid in urines of normal and schizophrenic individuals. Nature (Lond.) 211, 606–608 (1966).
Kuntzman, R., Sernatinger, E., Tsai, I., Klutch, A.: New methodology for studies of drug metabolism. In: Importance of fundamental principles in drug evaluation Ed. by D.H. Tedeschi and R.E. Tedeschi, pp. 87–103. New York: Raven Press 1968.
Lindgren, J.E., Hammer, C.G., Hessling, R., Holmstedt, B.: The chemical identity of “Hog” — a “new” hallucinogen. Amer. J. Pharm. 141, 86–90 (1969).
Llewelyn, P.M., Littlejohn, D.P.: Presented at the Pittsburgh Conference on analytical chemistry and applied spectroscopy, Pittsburgh, Pa. (1966); see also D.R. Black, R.A. Flath and R. Teranishi: Membrane molecular separators for gas chromatographic-mass spectrometric interfaces. J. Chromatographic Sci. 7, 284–289 (1969).
Luukkainen, T., Adlercreutz, H.: Mass spectrometric studies in the specificity of estriol determination in urine by gas-liquid chromatography. Ann. Med. exp. Fenn. 45, 264–268 (1967).
McLafferty, F.: Mass spectrometry of organic ions. New York: Academic Press 1963.
McLafferty, F.: Interpretation of mass spectra; an introduction. New York: W.A. Benjamin 1966.
McNair, H.M., Bonelli, E.J.: Basic gas chromatography. Consolidated Printers for Varian Aerograph, Walnut Creek, Calf. (1967).
Milne, G.W.A., Goldman, P., Holtzman, J.L.: The metabolism of 2-fluorobenzoic acid. II. Studies with 18O2. J. biol. Chem. 243, 5374–5376 (1968).
Mize, C.E., Avigan, J., Steinberg, D., Pittman, R.C., Fales, H.M., Melne, G.W.A.: A major pathway for the mammalian oxidative degradation of phytanic acid. Biochim. biophys. Acta (Amst.) 176, 720–739 (1969).
Nilsson, I.M., Agurell, S., Nilsson, J.L.G., Ohlsson, A., Sandberg, F., Wahlqvist, M.: Δ1-Tetrahydrocannabinol: Structure of a major metabolite. Science 168, 1228–1229 (1970).
Palmer, K.H., Fowler, M.S., Wall, M.E., Rhodes, L.S., Waddell, W.J., Baggett, B.: The metabolism of R (+)-and RS-phenobarbital. J. Pharmacol. exp. Ther. 170, 355–363 (1969).
Palmer, K.H., Martin, B., Baggett, B., Wall, M.E.: The metabolic fate of orally administered quinidine gluconate in humans. Biochem. Pharmacol. 18, 1845–1860 (1969).
Plimmer, J.R., Kearney, P.O., Von Endt, D.W.: Mechanism of conversion of DDT to DDD by Aerobacter aerogenes. J. Agr. Food Chem. 16, 594–597 (1968).
Reed, W.T., Forgash, A.J.: Lindane: Metabolism to a new isomer of pentachlorocyclohexene. Science 160, 1232 (1968).
Reisch, J., Pagnucco, R., Alfes, H., Jantos, N., Mollmann, H.: Mass spectra of derivatives of phenylalkylamines. J. Pharm. Pharmacol. 20, 81–86 (1968).
Rhodes, R.C., Reiser, R.W., Gardiner, J.A., Sherman, H.: Identification of the metabolites of terbacil in dog urine. J. Agr. Food Chem. 17, 974–979 (1969).
Ryhage, R.: Use of a mass spectrometer as a detector and analyses for effluents emerging from high temperature gas liquid chromatography columns. Anal. Chem. 36, 759–764 (1964).
Schwartz, M.A., Bommer, P., Vane, F.M.: Diazepam metabolites in the rat: Characterization by high resolution mass spectrometry and nuclear magnetic resonance. Arch. Biochem. 121, 508–516 (1967).
Schwartz, M.A., Vane, F.M., Postma, E.: Chlordiazepoxide metabolites in the rat. Characterization by high resolution mass spectrometry. Biochem. Pharmacol. 17, 965–974 (1968a).
Schwartz, M.A., Vane, F.M., Postma, E.: Urinary metabolites of 7-chloro-1-(2-diethylaminoethyl)-5-(2-flurophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride. J. med. Chem. 11, 770–774 (1968b).
Scott, W.M., Wacks, M.E., Eskelson, C.D., Towne, J.C., Cazee, C.: The elimination of small neutral molecules and fragments in mass spectra. — I. Substituted salicyclic acids and their derivatives. Org. Mass. Spect. 1, 847–855 (1968).
Seibl, J.: Information on metastable transitions in the mass spectra of organic compounds. Helv. chim. Acta 50, 263–268 (1967).
Silverstein, R.M., Bassler, G.C.: Spectrometric identification of organic compounds. 2nd Ed. New York: Wiley, 1967.
Sinshelmer, J.E., Smith, R.U.: 4,4′-Dihydroxybibenzyl, a reduction metabolite of trans-stilbene. J. pharm. Sci. 57, 713–714 (1968).
Sisenwine, S.F., Walkenstein, S.S.: The metabolic fate of the pteridine diuretic, Wy-5256. J. pharm. Sci. 58, 867–871 (1969).
Smith, D.L., Grostic, M.F.: Mass spectrometric identification of the metabolites of methyl N-(o-aminophenyl)-N-(3-dimethylaminopropyl) anthranilate. J. med. Chem. 10, 375–379 (1967).
von Spulak, F., Claussen, V., Fehlhaber, H.W., Korte, F.: Haschisch-XIX. Cannabidiolcarbonsäure-tetrahydrocannabitriol-ester, ein neuer Haschisch-Inhaltsstoff. Tetrahedron 24, 5379–5383 (1968).
Stenhagen, E.: Mass spectrometry in biochemical research. Chimia 20, 346–357 (1966).
Street, H.V.: Gas liquid chromatography of submicrogram amounts of drugs. IV. Identification of barbiturates, hydantoins, amides, imides, carbamates, phenylbutazone, carboxylic acids and hydrazine derivatives by direct derivative formation within the gas chromatograph. J. Chromat. 41, 358–366 (1969).
Suda, T., Deluca, H.F., Schnoes, H., Blunt, J.W.: 25-Hydroxyergocalciferol: A biologically active metabolite of Vitamin D2. Biochem. biophys. Res. Commun. 35, 182–185 (1969).
Szymanski, H.A.: Biomedical applications of gas chromatography. New York: Plenum Press 1964.
Thomas, D.W., Biemann, K.: The alkaloids of Voacanga africina. Lloydia 31, 1–8 (1968).
Wade, A.P., Wilkinson, G.S., Dean, F.M., Price, A.W.: The isolation characterization and structure of uroterpenol, a monoterpene from human urine. Biochem. J. 101, 727–734 (1966).
White, F.A.: Mass spectrometry in science and technology. New York: Wiley 1968.
Woltz, H.H., Clark, S.J.: Gas chromatography in the analysis of steroid hormones. New York: Plenum Press 1966.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Guarino, A.M., Fales, H.M. (1971). Gas Chromatography-Mass Spectrometry. In: Brodie, B.B., Gillette, J.R., Ackerman, H.S. (eds) Concepts in Biochemical Pharmacology. Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie, vol 28 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65177-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-65177-9_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65179-3
Online ISBN: 978-3-642-65177-9
eBook Packages: Springer Book Archive